European League Against Rheumatism recommendations for terminologyand diagnosis of calcium pyrophosphate crystal deposition disease: Expert comment

European League Against Rheumatism recommendations for terminologyand diagnosis of calcium pyrophosphate crystal deposition disease: Expert comment

Bibliographic Details
Main Author:	V G Barskova
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2011-06-01
Series:	Современная ревматология
Online Access:	https://mrj.ima-press.net/mrj/article/view/346

Similar Items

European League Against Rheumatism recommendations for terminology and diagnosis of calcium pyrophosphate crystal deposition disease: An expert's comments
by: Viktoriya Georgievna Barskova, et al.
Published: (2011-09-01)

OSTEOPOROSIS IN CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION DISEASE
by: S A Vladimirov, et al.
Published: (2013-02-01)

THE CLINICAL MANIFESTATIONS OF CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION DISEASE
by: F. M. Kudaeva, et al.
Published: (2014-09-01)

Rational approaches to diagnosing gout (according to the European Antirheumatic League Guidelines)
by: V G Barskova, et al.
Published: (2007-09-01)

According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments
by: T. V. Popkova, et al.
Published: (2019-11-01)

Experience with methotrexate in a patient with calcium pyrophosphate crystal deposition disease
by: E. V. Ilyinykh, et al.
Published: (2019-10-01)

Comparison of three radiodiagnostic techniques for pyrophosphate arthropathy
by: Fatima Magomedovna Kudayeva, et al.
Published: (2012-06-01)

Cardiovascular risk factors in patients with calcium pyrophosphate crystal deposition disease
by: M. S. Eliseev, et al.
Published: (2019-11-01)

Current strategy in the treatment of calcium pyrophosphate crystal deposition disease
by: S. A. Vladimirov, et al.
Published: (2019-01-01)

USE OF METHOTREXATE IN PATIENTS WITH CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION DISEASE
by: M. S. Eliseev, et al.
Published: (2018-05-01)

Advances in imaging for the assessment of calcium pyrophosphate deposition disease
by: S. Sirotti, et al.
Published: (2022-12-01)

Age-related features of calcium pyrophosphate deposition disease
by: M. S. Eliseev, et al.
Published: (2019-12-01)

The diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: the good, the bad and… ultrasonography!
by: B. Frediani, et al.
Published: (2012-07-01)

Calcium pyrophosphate deposition disease: clinical manifestations
by: M.A. Cimmino, et al.
Published: (2012-01-01)

Calcium Pyrophosphate Deposition Disease of the Temporomandibular Joint*
by: Vasisht Srinivasan, et al.
Published: (2012-09-01)

Review of the European League Against Rheumatism (EULAR) guidelines considered in 2018
by: T. V. Beketova
Published: (2019-05-01)

Diastolic dysfunction of the left and right ventricles in patients with calcium pyrophosphate crystal deposition disease and osteoarthritis
by: M. S. Eliseev, et al.
Published: (2023-03-01)

Recent advances in the therapeutic management of calcium pyrophosphate deposition disease
by: Paraskevi V. Voulgari, et al.
Published: (2024-03-01)

Calcification of coronary arteries in patients with calcium pyrophosphate crystal deposition disease and knee osteoarthritis
by: M. S. Eliseev, et al.
Published: (2021-09-01)

Cervical vertebrae affection in calcium pyrophosphate crystal deposition disease (description of a clinical case)
by: E. V. Cheremushkina, et al.
Published: (2021-10-01)

Diagnosis and Treatment of Calcium Pyrophosphate Deposition (CPPD) Disease: A Review
by: Cowley S, et al.
Published: (2023-03-01)

Calcium pyrophosphate crystal deposition disease as a risk factor for cardiovascular diseases
by: A. M. Novikova
Published: (2020-02-01)

Calcium pyrophosphate deposition disease: historical overview and potential gaps
by: Carlos Pineda, et al.
Published: (2024-04-01)

Diastolic dysfunction of ventricles in patients with calcium pyrophosphate crystal deposition disease while receiving anti-inflammatory therapy
by: Maxim S. Eliseev, et al.
Published: (2023-07-01)

Effect of colchicine, methotrexate, and hydroxychloroquine therapy on cardiovascular outcomes in patients with calcium pyrophosphate crystal deposition disease
by: M. S. Eliseev, et al.
Published: (2021-12-01)

The prevalence of subclinical atherosclerosis of carotid arteries in patients with calcium pyrophosphate crystal deposition disease and osteoarthritis (pilot study)
by: M. S. Eliseev, et al.
Published: (2021-10-01)

Two cases of calcium pyrophosphate deposition disease (CPPD) presented with spondylodiscitis
by: Tuğba İzci Duran, et al.
Published: (2020-04-01)

The use of Anakinra in treatment of calcium pyrophosphate crystal deposition disease: Analysis of own experience and a literature review
by: M. S. Eliseev, et al.
Published: (2022-12-01)

Editor's letter
by: V G Barskova, et al.
Published: (2011-06-01)

The monograph «Behchet's disease» by Z.S. Alekberova
by: V G Barskova, et al.
Published: (2008-03-01)

Rational approaches to treating gout
by: V G Barskova, et al.
Published: (2008-03-01)

The effect of therapy on subclinical atherosclerosis of the carotid arteries in patients with calcium pyrophosphate crystal deposition disease and osteoarthritis (pilot study)
by: M. S. Eliseev, et al.
Published: (2021-12-01)

Tumor necrosis factor α (TNFα) role in the development of metabolic disturbances and atherosclerosis and TNFα antagonists influence on them in patients with rheumatic diseases
by: M S Eliseev, et al.
Published: (2009-04-01)

Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)’s recommendations for cardiovascular risk management?
by: Conrad, N, et al.
Published: (2022)

Trunnionosis in total hip arthroplasty with accompanying amyloidosis and calcium pyrophosphate deposition disease
by: Kevin Christopher Serdysnki, DO, et al.
Published: (2024-01-01)

Acute Calcium Pyrophosphate Deposition at the Surgical Site after Posterior Lumbar Decompression
by: Ikko Koike, et al.
Published: (2023-03-01)

Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.
by: Andrew, L, et al.
Published: (1999)

PYROPHOSPHATE ARTHROPATHY IS A RHEUMATOLOGICAL ICEBERG SYNDROME: TIME TO REASSESS ITS IMPORTANCE IN JOINT DISEASES
by: Viktoria Georgiyevna Barskova, et al.
Published: (2010-06-01)

Bioceramics Based on β-Calcium Pyrophosphate
by: Tatiana Safronova, et al.
Published: (2022-04-01)

Polydatin Prevents Calcium Pyrophosphate Crystal-Induced Arthritis in Mice
by: Francesca Oliviero, et al.
Published: (2021-03-01)